AnalyzeDirect Zachariah P. Tritz et al. Anti-PD-1 and extended half-life-IL-2 synergize for treatment of murine glioblastoma independent of host MHC Class I expression Cancer Immunology Research.
Publication Date
March 15, 2023
How Analyze was Used
“Volumes of the tumors were 129 determined using Analyze 12.0 software as 130 traced by a blinded reviewer on the transverse plane and then generated into a 3-Dimensional render.”
Keywords
Anti-PD-1, Extended half-life-IL-2, Murine, Glioblastoma, Host MHC Class I expression
Author Affiliation(s)
Mayo Clinic, Rochester, Minnesota, USA
